相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair
Qin Qin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity
Georg E. Winter et al.
NATURE CHEMICAL BIOLOGY (2014)
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
K. G. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Open Comet: An automated tool for comet assay image analysis
Benjamin M. Gyori et al.
REDOX BIOLOGY (2014)
YM155 induces caspase-8 dependent apoptosis through downregulation of survivin and Mcl-1 in human leukemia cells
Weiying Feng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening
Jeffrey W. Tyner et al.
CANCER RESEARCH (2013)
A Phase I Study of EZN-3042, a Novel Survivin Messenger Ribonucleic Acid (mRNA) Antagonist, Administered in Combination With Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
Elizabeth A. Raetz et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2013)
A 50-Year Journey to Cure Childhood Acute Lymphoblastic Leukemia
Ching-Hon Pui et al.
SEMINARS IN HEMATOLOGY (2013)
Survivin Inhibitor YM-155 Sensitizes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Resistant Glioma Cells to Apoptosis through Mcl-1 Downregulation and by Engaging the Mitochondrial Death Pathway
Daniel R. Premkumar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
Yan-Fang Tao et al.
BMC CANCER (2012)
The survivin suppressants NSC 80467 and YM155 induce a DNA damage response
Trevor G. Glaros et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Targeting survivin and p53 in pediatric acute lymphoblastic leukemia
J. W. Tyner et al.
LEUKEMIA (2012)
Endogenous knockdown of survivin improves chemotherapeutic response in ALL models
D. J. Morrison et al.
LEUKEMIA (2012)
Mcl-1 downregulation by YM155 contributes to its synergistic anti-tumor activities with ABT-263
Haikuo Tang et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia
Eugene Park et al.
BLOOD (2011)
Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models
Takahito Nakahara et al.
CANCER SCIENCE (2011)
Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3
Seiji Fukuda et al.
BLOOD (2009)
Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
Taroh Satoh et al.
CLINICAL CANCER RESEARCH (2009)
An optimized method for measurement of gamma-H2AX in blood mononuclear and cultured cells
Aida Muslimovic et al.
NATURE PROTOCOLS (2008)
Opinion - Survivin, cancer networks and pathway-directed drug discovery
Dario C. Altieri
NATURE REVIEWS CANCER (2008)
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
Takahito Nakahara et al.
CANCER RESEARCH (2007)
Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia
Anja Troeger et al.
HAEMATOLOGICA (2007)
ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression
Michael Baudis et al.
PEDIATRIC BLOOD & CANCER (2006)
Profiling of DNA replication timing in unsynchronized cell populations
Veronique Azuara
NATURE PROTOCOLS (2006)
Phosphatases join kinases in DNA-damage response pathways
CJ Bakkenist et al.
TRENDS IN CELL BIOLOGY (2004)
DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells
MX Zhou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34+ cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells
S Fukuda et al.
BLOOD (2002)
Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa
R Gianani et al.
HUMAN PATHOLOGY (2001)
分享论文
